Thursday, September 15, 2016

EASD: Novel SGLT2 Drug Works in Triple Therapy (CME/CE)

(MedPage Today) -- Ertugliflozin improved T2D control atop metformin/sitagliptin
via EASD: Novel SGLT2 Drug Works in Triple Therapy (CME/CE)
by

No comments:

Post a Comment